The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”

American Journal of Bioethics 14 (4):59-60 (2014)
  Copy   BIBTEX

Abstract

No abstract

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,247

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2014-04-15

Downloads
45 (#492,483)

6 months
13 (#257,195)

Historical graph of downloads
How can I increase my downloads?